Possible aminergic mediation of MSH release and of the CNS effects of MSH and MIF-I.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Federation proceedings

• Publication date

  1980-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 6105977
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The arrangement of neurosecretory and catecholamine fibres in relation to the pituitary intermedia cells of the skate, Raja radiata

  2004cited by this paper
• MSH and MIF-I in animal models of tardive dyskinesia.

  1980cited by this paper
• Striatal dopamine turnover and MIF-I.

  1979cited by this paper
• MIF-I and postsynaptic receptor sites for dopamine.

  1979cited by this paper
• Control of the pars intermedia of the lizard, Anolis carolinensis

  1979cited by this paper
• CNS effects of peripherally administered brain peptides.

  1979cited by this paper
• The influence of the nervous system upon adrenal gland weight and assayable pituitary MSH.

  1978cited by this paper
• Serotonin and MSH secretion: Effect of Parachlorophenylalanine on the pituitary cytology of the eel

  1978cited by this paper
• Action potentials in gland cells of rat pituitary pars intermedia: inhibition by dopamine, an inhibitor of MSH secretion

  1978cited by this paper
• Effect of pimozide on the cytology of the eel pituitary

  1978cited by this paper
• Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide.

  1978cited by this paper
• An improved radioimmunoassay for alpha-melanocyte-stimulating hormone (alpha-MSH) in the rat: serum and pituitary alpha-MSH levels after drugs which modify catecholaminergic neurotransmission.

  1978cited by this paper
• Prolyl-leucyl-glycinamide (PLG); regional effects on alpha-MPT-induced catecholamine disappearance in rat brain.

  1978cited by this paper
• Pars intermedia electrical potentials: changes in spike frequency induced by regulatory factors of melanocyte stimulating hormone (MSH) secretion.

  1978cited by this paper
• Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part III: effect of L-prolyl-N-methyl-D-leucyl-glycinamide and MIF on biogenic amine turnover.

  1977cited by this paper
• Effects of pimozide and bromocriptine on the proliferation of rat pituitary pars intermedia cells.

  1977cited by this paper
• The effect of alpha-melanocyte stimulating hormone (alpha-msh) on the metabolism of biogenic amines in the rat brain.

  1976cited by this paper
• Ergot alkaloid inhibition of melanophore stimulating hormone secretion.

  1976cited by this paper
• Immuno-enzyme cytochemical demonstration of mesotocinergic nerve fibres in the pars intermedia of the amphibian hypophysis

  1976cited by this paper
• Some questions related to melanocyte-stimulating hormone.

  1976cited by this paper
• Effects of L-prolyl-L-leucyl-glycine amide (MIF-I) on dopaminergic neurons.

  1976cited by this paper
• Ability of various factors to oppose the stimulatory effect of dibutyrylcyclic AMP on the release of melanocyte-stimulating hormone by the rat pituitary in vitro.

  1976cited by this paper
• Investigations on alpha-MSH and MIF-1 effects on cyclic AMP levels in rat brain.

  1976cited by this paper
• Possible association of increased rat behavioral effects and increased striatal dopamine and norepinephrine levels during the DOPA-potentiation test.

  1976cited by this paper
• Effect of ACTH4–10 on the rate of synthesis of [3H]catecholamines in the brains of intact, hypophysectomized and adrenalectomized rats

  1975cited by this paper
• Cellular mechanisms controlling melanophore stimulating hormone (MSH) release.

  1975cited by this paper
• The effect of apomorphine and ergocriptine on the release of MSH by the pars intermedia of Rana pipiens.

  1975cited by this paper
• Alpha-MSH and MIF-2 effects on serotonin levels and accumulation in various rat brain areas.

  1975cited by this paper
• Biogenic Amines and Control of Melanophore Stimulating Hormone Release

  1974cited by this paper
• The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain.

  1974cited by this paper
• DOPA potentiation in ablated animals and brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide.

  1974cited by this paper
• The effect of catecholamines on the pars intermedia autotransplanted into the anterior chamber of the eye of the frog, Rana nigromaculata.

  1974cited by this paper
• Effect of two ACTH-analogs on noradrenaline metabolism in rat brain.

  1973cited by this paper
• A relationship between adrenergic blockage and the secretory process in cells of the pars intermedia of the frog Rana pipiens.

  1973cited by this paper
• Effects of pharmacological agents on the in vivo release of melanophore-stimulating hormone in the dogfish, Scyliorhinus canicula.

  1973cited by this paper
• Evidence for the release of MSH by phenothiazine ataraxics.

  1972cited by this paper
• Role of catecholamines in the control of melanocyte-stimulating hormone secretion in rats.

  1972cited by this paper
• DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).

  1971cited by this paper
• Further evidences for the blocking effect of catecholamines on the secretion of melanocyte-stimulating hormone in toads.

  1969cited by this paper
• MSH activity in plasma and pituitaries of rats after various treatments.

  1969cited by this paper
• The antagonism by thymoleptics of the reserpine-induced expansion of melanophores in the pencil fish.

  1968cited by this paper
• Effects of pharmacological agents on the hypothalamus of Rana pipiens in relation to the control of skin melanophores.

  1966cited by this paper
• Monoamines and control of the pars intermedia of the toad pituitary.

  1966cited by this paper
• Monoamines and the pituitary gland.

  1966cited by this paper
• MSH activity in pituitary glands of rats treated with tranquilizing drugs.

  1966cited by this paper
• On the presence of adrenergic nerves in the pars intermedia of the frog, Rana temporaria.

  1965cited by this paper
• THE EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE ON THE MELANOPHORES OF THE TOAD BUFO ARENARUM UNDER DIFFERENT EXPERIMENTAL CONDITIONS.

  1965cited by this paper
• Relative Effectiveness of Phenothiazine Tranquilizing Drugs Causing Release of MSH.∗ †

  1961cited by this paper
• Melanophore-Dispersing Activity of Reserpine in Rana Frogs.∗

  1961cited by this paper
• Inhibition of the secretion of intermedine by D-lysergic acid diethylamide (LSD 25) in the toad, Xenopus laevis.

  1958cited by this paper
• [Effect of 5-hydroxytryptamine on pigmentation system of skin].

  1957cited by this paper
• Cholinergic stimulation of the release of melanophore hormone by the hypophysis in salamander larvae.

  1947cited by this paper

• Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome

  2017cites this paper
• Colocalization of somatostatin receptor subtypes (SSTR1–5) with somatostatin, NADPH‐diaphorase (NADPH‐d), and tyrosine hydroxylase in the rat hypothalamus

  2007cites this paper
• From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides.

  2007cites this paper
• Plasma beta-lipotropin levels in Parkinson's disease

  2005cites this paper
• The Tyr-MIF-1 family of peptides.

  1994cites this paper
• Novel Concepts from Novel Peptides

  1994cites this paper
• Asymmetric distribution of brain monoamines in left- and right-handed mice.

  1990cites this paper
• alpha-Melanocyte-stimulating hormone infused ICV fails to affect body temperature or endotoxin fever in the cat.

  1986cites this paper
• Absence of inhibitory dopaminergic control of the rabbit pituitary gland intermediate lobe.

  1986cites this paper
• Oxytocin and vasopressin in rat hypophysial portal blood: experimental studies in normal and Brattleboro rats.

  1985cites this paper
• Störung der Exkretion von Hautoberflächenlipiden beim Parkinsonsyndrom

  1985cites this paper
• Pro-Leu-GlyNH2 affects dopamine and noradrenaline utilization in rat limbic-forebrain nuclei.

  1984cites this paper
• Evidence for conversion of N-Tyr-MIF-1 into MIF-1 by a specific brain aminopeptidase.

  1984cites this paper
• Distribution of catecholamine neurons in the hypothalamus and preoptic region of mouse

  1984cites this paper
• Melanin: the organizing molecule.

  1983cites this paper
• Variations in number of dopamine neurons and tyrosine hydroxylase activity in hypothalamus of two mouse strains

  1983cites this paper
• Minireview. Brain peptides: the dangers of constricted nomenclatures.

  1983cites this paper
• Behavioral effects of melanocyte stimulating hormone release-inhibiting factor-1 (MIF-1).

  1983cites this paper
• Grundlagen der Endokrinologie

  1982cites this paper
• Modification of d-amphetamine- or chlorpromazine-induced hypothermia by beta-endorphin, MIF-I, and alpha-MSH: mediation by the dopaminergic system.

  1982cites this paper
• Some Other Notable Brain Peptides

  1982cites this paper
• Neurohypophyseal hormones and brain neurochemistry.

  1982cites this paper
• CHAPTER 26 – Multiple Independent Actions of Neuropeptides on Behavior

  1981cites this paper
• Mu and delta opiate receptors in rat brain are affected by GTP but not by MIF-1.

  1981cites this paper
• Radioimmunoassayable N-Tyr-MIF-1-like activity in rat brain is increased by pinealectomy.

  1981cites this paper
• Peptides and thermoregulation.

  1980cites this paper
• Interaction of MIF-I or alpha-MSH with D-amphetamine or chlorpromazine on thermoregulation and motor activity of rats maintained at different ambient temperatures.

  1980cites this paper
• Antagonistic actions of MIF-I on the hypothermia and hypomotility induced by beta-endorphin or morphine.

  1980cites this paper
• Behavioral effects of melanocyte stimulating hormone.

  1980cites this paper